[Remote] Senior Oncology Medical Science Liaison (Sr. MSL) – Mountain at Bristol-Myers Squibb

United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Pharmaceuticals, Oncology, Medical DevicesIndustries

Requirements

Candidates must possess a strong scientific background, likely with an advanced degree (MD, PharmD, PhD) in a relevant scientific or clinical discipline. Experience as a Medical Science Liaison (MSL) in oncology, specifically within radiopharmaceuticals or solid tumors, is required. Proven ability to develop and maintain relationships with Key Opinion Leaders (KOLs) and Healthcare Providers (HCPs) is essential. Extensive travel is expected for this role.

Responsibilities

The Senior MSL will serve as the primary medical resource to the external healthcare community, engaging in peer-to-peer scientific exchange with KOLs and HCPs. They will identify medical needs within their territory, facilitate access to clinical trial compounds and marketed products, and ensure their safe and appropriate use. Responsibilities include gathering medical insights, acting as a clinical and scientific advisor, and collaborating with internal teams on clinical development, operations, and medical affairs. The role involves preparing for product launches, executing scientific exchange strategies, and representing the company credibly at conferences and scientific events.

Skills

Oncology

Medical Science Liaison

Biotechnology

Radioisotopes

Radiopharmaceuticals

Clinical Trials

Solid Tumors

Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Small Cell Lung Cancer (SCLC)

Breast Cancer

Communication

Relationship Building

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free